RPRX
Royalty Pharma PLC
$58.56
0.66 (1.11%) Today
— up— down
Market Cap
$34.05B+60.6%
Revenue (TTM)
$2.62B+10.0%
Net Income (TTM)
$841.00M-15.9%
EPS (TTM)
1.46-15.9%
Shares Out
575.83M
575.83MP/E Ratio
40.90
40.90Forward P/E
10.85
10.85Dividend
$0.65 (1.59%)
$0.65 (1.59%)Ex-Dividend Date
May 15, 2026
May 15, 2026Open
$59.50
$59.50Previous Close
$59.22
$59.22Day Range
$57.95 – $59.58
$57.95 – $59.5852-Week Range
$34.08 – $60.44
$34.08 – $60.44Beta
0.41
0.41Volume
2.43M
2.43MAvg Volume
3.47M
3.47MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout RPRX
Royalty Pharma is a private equity investor firm founded in 1996. It purchases the rights to royalties on future drug sales. It claims to own partial rights to 7 of the top 30 selling drugs in the United States.
